Clinical trials
Carcinoma, Ovarian Epithelial trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 9 |
| 2020 | 9 |
| 2021 | 7 |
| 2022 | 7 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 34 |
| Recruiting | 15 |
| Active, not recruiting | 6 |
| Completed | 5 |
| Not yet recruiting | 5 |
| Terminated | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lei Li | 13 |
| Shanghai Gynecologic Oncology Group | 6 |
| AstraZeneca | 3 |
| Beijing Biotech | 3 |
| RenJi Hospital | 3 |
| Peking Union Medical College Hospital | 2 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 2 |
| Women's Hospital School Of Medicine Zhejiang University | 2 |
| Xiaoxiang Chen | 2 |
| AbbVie | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 69 |
| Fallopian Tube Neoplasms | 24 |
| Ovarian Neoplasms | 23 |
| Carcinoma | 5 |
| Neoplasms | 5 |
| Genital Diseases, Female | 3 |
| Genital Neoplasms, Female | 3 |
| Neoplasms by Histologic Type | 3 |
| Neoplasms by Site | 3 |
| Neoplasms, Glandular and Epithelial | 3 |
Trials
Showing 76 to 69 of 69. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.